AstraZeneca COVID-19 Vaccine 76% Effective In Updated US Trial Results

  • 6:14
  • Published On: March 25, 2021
Cinema View
Embed
AstraZeneca said on Thursday its COVID-19 vaccine was 76% effective at preventing symptomatic illness, citing a new analysis of up-to-date results for its major US trial.

Related Videos

Serum Institute Offers Free Vaccine Doses to Centre, Other Top Stories
December 29, 2022 53:57
Serum Institute To Provide 2 Crore Covishield Doses To Centre For Free
December 29, 2022 1:27
Top Headlines Of The Day: December 29, 2022
December 29, 2022 1:28
India's First Vaccine Against Cervical Cancer Launched
September 02, 2022 1:17
Cervical Cancer: India Launches Vaccine Against Cervical Cancer
September 01, 2022 1:07
Serum Institute Now Has 4 Billion Doses Vaccine Capacity: Adar Poonawalla
July 26, 2022 1:40
May Take 2-3 Months To Import Monkeypox Vaccines: Adar Poonawalla
July 26, 2022 1:35
"No Monkeypox Vaccine Plans For Now": Serum Institute's Adar Poonawalla
July 26, 2022 18:27
"For A New Variant, We Need 6 To 7 Months For New Shot": Adar Poonawalla To NDTV
May 05, 2022 4:01
"Covovax Jab And Booster Have More Than 90% Efficacy": Adar Poonawalla To NDTV
May 05, 2022 3:36
"India Much Better In Hospitalisation Rate Than West": Adar Poonawalla To NDTV
May 05, 2022 2:29
Vaccine Fatigue Behind Poor Booster Response: Adar Poonawalla To NDTV
May 05, 2022 26:09
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination